{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T20:45:44Z","timestamp":1788295544811,"version":"build-2803163510"},"reference-count":183,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001773","name":"University of New South Wales","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001773","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001775","name":"University of Technology Sydney","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001775","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1080521"],"award-info":[{"award-number":["1080521"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1148595"],"award-info":[{"award-number":["1148595"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001171","name":"Cancer Institute NSW","doi-asserted-by":"publisher","award":["14\/TPG\/1-05"],"award-info":[{"award-number":["14\/TPG\/1-05"]}],"id":[{"id":"10.13039\/501100001171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Ocular Surface"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.jtos.2021.06.007","type":"journal-article","created":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T05:54:27Z","timestamp":1623822867000},"page":"221-237","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Corneal nerve changes following treatment with neurotoxic anticancer drugs"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6133-7411","authenticated-orcid":false,"given":"Jeremy Chung Bo","family":"Chiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna B.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun V.","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Markoulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtos.2021.06.007_bib1","first-page":"7","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA A Cancer J Clin"},{"key":"10.1016\/j.jtos.2021.06.007_bib2","first-page":"605","article-title":"Microbiome-gut-brain axis in cancer treatment-related psychoneurological toxicities and symptoms: a systematic review","volume":"29","author":"Song","year":"2021","journal-title":"Support Care Canc"},{"key":"10.1016\/j.jtos.2021.06.007_bib3","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.gaitpost.2020.01.012","article-title":"Out of balance \u2013 postural control in cancer patients before and after neurotoxic chemotherapy","volume":"77","author":"M\u00fcller","year":"2020","journal-title":"Gait Posture"},{"key":"10.1016\/j.jtos.2021.06.007_bib4","first-page":"41","article-title":"Adjuvant and neoadjuvant treatment of triple-negative breast cancer with chemotherapy","volume":"27","author":"Marra","year":"2021","journal-title":"Canc J"},{"key":"10.1016\/j.jtos.2021.06.007_bib5","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nrclinonc.2015.152","article-title":"Cancer-treatment-induced neurotoxicity--focus on newer treatments","volume":"13","author":"Stone","year":"2016","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.jtos.2021.06.007_bib6","doi-asserted-by":"crossref","first-page":"113244","DOI":"10.1016\/j.expneurol.2020.113244","article-title":"Characteristics of the nerve barrier and the blood dorsal root ganglion barrier in health and disease","volume":"327","author":"Reinhold","year":"2020","journal-title":"Exp Neurol"},{"key":"10.1016\/j.jtos.2021.06.007_bib7","first-page":"419","article-title":"Chemotherapy-induced peripheral neurotoxicity: a critical analysis","volume":"63","author":"Park","year":"2013","journal-title":"CA A Cancer J Clin"},{"key":"10.1016\/j.jtos.2021.06.007_bib8","first-page":"4163","article-title":"Reporting of paclitaxel-induced peripheral neuropathy symptoms to clinicians among women with breast cancer: a qualitative study","volume":"28","author":"Salgado","year":"2020","journal-title":"Support Care Canc"},{"key":"10.1016\/j.jtos.2021.06.007_bib9","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/j.pain.2014.09.020","article-title":"Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis","volume":"155","author":"Seretny","year":"2014","journal-title":"Pain"},{"key":"10.1016\/j.jtos.2021.06.007_bib10","first-page":"913848","article-title":"Healthcare costs and workloss burden of patients with chemotherapy-associated peripheral neuropathy in breast, ovarian, head and neck, and nonsmall cell lung cancer","volume":"2012","author":"Pike","year":"2012","journal-title":"Chemother Res Pract"},{"key":"10.1016\/j.jtos.2021.06.007_bib11","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1136\/jnnp-2017-317215","article-title":"Incidence and disease burden of chemotherapy-induced peripheral neuropathy in a population-based cohort","volume":"89","author":"Shah","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jtos.2021.06.007_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9082400","article-title":"Long-term prevalence of sensory chemotherapy-induced peripheral neuropathy for 5 years after adjuvant FOLFOX chemotherapy to treat colorectal cancer: a multicenter cross-sectional study","volume":"9","author":"Selvy","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.jtos.2021.06.007_bib13","first-page":"3485","article-title":"Optimal clinical assessment strategies for chemotherapy-induced peripheral neuropathy (CIPN): a systematic review and Delphi survey","volume":"25","author":"McCrary","year":"2017","journal-title":"Support Care Canc"},{"key":"10.1016\/j.jtos.2021.06.007_bib14","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1200\/JCO.2006.05.6689","article-title":"Development of neuropathy in patients with myeloma treated with thalidomide: patterns of occurrence and the role of electrophysiologic monitoring","volume":"24","author":"Mileshkin","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtos.2021.06.007_bib15","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/jns.12413","article-title":"Oxaliplatin- and docetaxel-induced polyneuropathy: clinical and neurophysiological characteristics","volume":"25","author":"Bennedsgaard","year":"2020","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.jtos.2021.06.007_bib16","doi-asserted-by":"crossref","first-page":"180428","DOI":"10.1155\/2014\/180428","article-title":"Bortezomib treatment produces nocifensive behavior and changes in the expression of TRPV1, CGRP, and substance P in the rat DRG, spinal cord, and sciatic nerve","volume":"2014","author":"Quartu","year":"2014","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.jtos.2021.06.007_bib17","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.npep.2014.02.001","article-title":"Peptidergic intraepidermal nerve fibers in the skin contribute to the neuropathic pain in paclitaxel-induced peripheral neuropathy","volume":"48","author":"Ko","year":"2014","journal-title":"Neuropeptides"},{"key":"10.1016\/j.jtos.2021.06.007_bib18","series-title":"Clinical and biochemical markers in CIPN: a reappraisal","author":"Bonomo","year":"2021"},{"key":"10.1016\/j.jtos.2021.06.007_bib19","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.exer.2009.12.010","article-title":"Anatomy of the human corneal innervation","volume":"90","author":"Marfurt","year":"2010","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jtos.2021.06.007_bib20","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0014-4835(03)00050-2","article-title":"Corneal nerves: structure, contents and function","volume":"76","author":"M\u00fcller","year":"2003","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jtos.2021.06.007_bib21","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12868-015-0190-2","article-title":"The effects of preferential A- and C-fibre blocks and T-type calcium channel antagonist on detection of low-force monofilaments in healthy human participants","volume":"16","author":"Nagi","year":"2015","journal-title":"BMC Neurosci"},{"key":"10.1016\/j.jtos.2021.06.007_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035817","article-title":"Thermal detection thresholds of A\u03b4- and C-fibre afferents activated by brief CO2 laser pulses applied onto the human hairy skin","volume":"7","author":"Churyukanov","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.jtos.2021.06.007_bib23","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1007\/s00125-018-4653-8","article-title":"Corneal confocal microscopy for identification of diabetic sensorimotor polyneuropathy: a pooled multinational consortium study","volume":"61","author":"Perkins","year":"2018","journal-title":"Diabetologia"},{"issue":"21","key":"10.1016\/j.jtos.2021.06.007_bib24","article-title":"Corneal confocal microscopy: a biomarker for diabetic peripheral neuropathy","author":"Petropoulos","year":"2021","journal-title":"Clin Therapeut"},{"key":"10.1016\/j.jtos.2021.06.007_bib25","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.clinph.2017.04.009","article-title":"Neurophysiological and clinical outcomes in chemotherapy-induced neuropathy in cancer","volume":"128","author":"Kandula","year":"2017","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.jtos.2021.06.007_bib26","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1158\/1535-7163.MCT-19-0133","article-title":"Oxaliplatin-DNA adducts as predictive biomarkers of FOLFOX response in colorectal cancer: a potential treatment optimization strategy","volume":"19","author":"Zimmermann","year":"2020","journal-title":"Mol Canc Therapeut"},{"key":"10.1016\/j.jtos.2021.06.007_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21228636","article-title":"Platinum-based drugs cause mitochondrial dysfunction in cultured dorsal root ganglion neurons","volume":"21","author":"Leo","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtos.2021.06.007_bib28","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1152\/jn.00260.2020","article-title":"Acute changes in nerve excitability following oxaliplatin treatment in mice","volume":"124","author":"Makker","year":"2020","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.jtos.2021.06.007_bib29","first-page":"5059","article-title":"Comparison of oxaliplatin and paclitaxel-induced neuropathy (Alliance A151505)","volume":"24","author":"Pachman","year":"2016","journal-title":"Support Care Canc"},{"key":"10.1016\/j.jtos.2021.06.007_bib30","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.npep.2017.12.002","article-title":"Oxaliplatin-induced changes in expression of transient receptor potential channels in the dorsal root ganglion as a neuropathic mechanism for cold hypersensitivity","volume":"67","author":"Chukyo","year":"2018","journal-title":"Neuropeptides"},{"key":"10.1016\/j.jtos.2021.06.007_bib31","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.pain.2013.05.032","article-title":"An animal model of oxaliplatin-induced cold allodynia reveals a crucial role for Nav 1.6 in peripheral pain pathways","volume":"154","author":"Deuis","year":"2013","journal-title":"Pain"},{"key":"10.1016\/j.jtos.2021.06.007_bib32","doi-asserted-by":"crossref","first-page":"6704","DOI":"10.1073\/pnas.1118058109","article-title":"Anticancer drug oxaliplatin induces acute cooling-aggravated neuropathy via sodium channel subtype Na(V)1.6-resurgent and persistent current","volume":"109","author":"Sittl","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtos.2021.06.007_bib33","first-page":"833","article-title":"Cisplatin-associated neuropathy characteristics compared with those associated with other neurotoxic chemotherapy agents (Alliance A151724)","volume":"29","author":"Albany","year":"2021","journal-title":"Support Care Canc"},{"issue":"Suppl 2","key":"10.1016\/j.jtos.2021.06.007_bib34","first-page":"S26","article-title":"Platinum-induced peripheral neurotoxicity: from pathogenesis to treatment","volume":"24","author":"Staff","year":"2019","journal-title":"J Peripher Nerv Syst"},{"issue":"Suppl 2","key":"10.1016\/j.jtos.2021.06.007_bib35","first-page":"S40","article-title":"Taxane and epothilone-induced peripheral neurotoxicity: from pathogenesis to treatment","volume":"24","author":"Tamburin","year":"2019","journal-title":"J Peripher Nerv Syst"},{"issue":"Suppl 2","key":"10.1016\/j.jtos.2021.06.007_bib36","first-page":"S63","article-title":"Vinca alkaloids, thalidomide and eribulin-induced peripheral neurotoxicity: from pathogenesis to treatment","volume":"24","author":"Islam","year":"2019","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.jtos.2021.06.007_bib37","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1016\/j.celrep.2019.10.085","article-title":"Interleukin-17 regulates neuron-glial communications, synaptic transmission, and neuropathic pain after chemotherapy","volume":"29","author":"Luo","year":"2019","journal-title":"Cell Rep"},{"key":"10.1016\/j.jtos.2021.06.007_bib38","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1097\/j.pain.0000000000001831","article-title":"Targeting interleukin-20 alleviates paclitaxel-induced peripheral neuropathy","volume":"161","author":"Chen","year":"2020","journal-title":"Pain"},{"key":"10.1016\/j.jtos.2021.06.007_bib39","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1097\/ALN.0000000000000176","article-title":"Enhanced excitability of primary sensory neurons and altered gene expression of neuronal ion channels in dorsal root ganglion in paclitaxel-induced peripheral neuropathy","volume":"120","author":"Zhang","year":"2014","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jtos.2021.06.007_bib40","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.neuroscience.2011.06.085","article-title":"Proteinase-activated receptor 2 sensitizes transient receptor potential vanilloid 1, transient receptor potential vanilloid 4, and transient receptor potential ankyrin 1 in paclitaxel-induced neuropathic pain","volume":"193","author":"Chen","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.jtos.2021.06.007_bib41","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s00424-011-1071-x","article-title":"TRPA1 and TRPV4 mediate paclitaxel-induced peripheral neuropathy in mice via a glutathione-sensitive mechanism","volume":"463","author":"Materazzi","year":"2012","journal-title":"Pfl\u00fcgers Archiv"},{"key":"10.1016\/j.jtos.2021.06.007_bib42","doi-asserted-by":"crossref","first-page":"3970","DOI":"10.1038\/s41598-020-60990-8","article-title":"Paclitaxel-induced peripheral neuropathy is caused by epidermal ROS and mitochondrial damage through conserved MMP-13 activation","volume":"10","author":"Cirrincione","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtos.2021.06.007_bib43","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1529-8027.2006.0090.x","article-title":"Evidence for direct axonal toxicity in vincristine neuropathy","volume":"11","author":"Silva","year":"2006","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.jtos.2021.06.007_bib44","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jphs.2017.03.004","article-title":"Vincristine-induced peripheral neuropathic pain and expression of transient receptor potential vanilloid 1 in rat","volume":"133","author":"Chiba","year":"2017","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.jtos.2021.06.007_bib45","doi-asserted-by":"crossref","first-page":"22382","DOI":"10.1074\/jbc.M100938200","article-title":"Inhibition of NF-kappa B activity by thalidomide through suppression of IkappaB kinase activity","volume":"276","author":"Keifer","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jtos.2021.06.007_bib46","first-page":"1361","article-title":"Neurophysiological, nerve imaging and other techniques to assess chemotherapy-induced peripheral neurotoxicity in the clinical and research settings","volume":"90","author":"Argyriou","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jtos.2021.06.007_bib47","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.neuro.2016.05.004","article-title":"Inhibition of the neuronal NF\u03baB pathway attenuates bortezomib-induced neuropathy in a mouse model","volume":"55","author":"Al\u00e9","year":"2016","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.jtos.2021.06.007_bib48","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.expneurol.2012.08.023","article-title":"Mitotoxicity and bortezomib-induced chronic painful peripheral neuropathy","volume":"238","author":"Zheng","year":"2012","journal-title":"Exp Neurol"},{"key":"10.1016\/j.jtos.2021.06.007_bib49","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.expneurol.2006.11.010","article-title":"Bortezomib-induced peripheral neurotoxicity: a neurophysiological and pathological study in the rat","volume":"204","author":"Cavaletti","year":"2007","journal-title":"Exp Neurol"},{"key":"10.1016\/j.jtos.2021.06.007_bib50","doi-asserted-by":"crossref","DOI":"10.1177\/1744806919837429","article-title":"Bortezomib-induced aerobic glycolysis contributes to chemotherapy-induced painful peripheral neuropathy","volume":"15","author":"Ludman","year":"2019","journal-title":"Mol Pain"},{"key":"10.1016\/j.jtos.2021.06.007_bib51","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/CND.0000000000000077","article-title":"Bortezomib-associated demyelinating neuropathy-clinical and pathologic features","volume":"16","author":"Thawani","year":"2015","journal-title":"J Clin Neuromuscul Dis"},{"key":"10.1016\/j.jtos.2021.06.007_bib52","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1529-8027.2008.00193.x","article-title":"Characteristics of bortezomib- and thalidomide-induced peripheral neuropathy","volume":"13","author":"Chaudhry","year":"2008","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.jtos.2021.06.007_bib53","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1158\/1078-0432.CCR-13-0541","article-title":"Trastuzumab emtansine: a novel antibody-drug conjugate for HER2-positive breast cancer","volume":"20","author":"Krop","year":"2014","journal-title":"Clin Canc Res"},{"key":"10.1016\/j.jtos.2021.06.007_bib54","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/bcr3621","article-title":"Trastuzumab emtansine: mechanisms of action and drug resistance","volume":"16","author":"Barok","year":"2014","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.jtos.2021.06.007_bib55","first-page":"3197","volume":"124","author":"Ansell","year":"2014","journal-title":"Brentuximab vedotin. Blood."},{"key":"10.1016\/j.jtos.2021.06.007_bib56","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1200\/JCO.20.01399","article-title":"Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: ASCO guideline update","volume":"38","author":"Loprinzi","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtos.2021.06.007_bib57","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.annonc.2020.07.003","article-title":"Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO-EONS-EANO Clinical Practice Guidelines for diagnosis, prevention, treatment and follow-up","volume":"31","author":"Jordan","year":"2020","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jtos.2021.06.007_bib58","article-title":"A systematic review of behavioural and exercise interventions for the prevention and management of chemotherapy-induced peripheral neuropathy symptoms","author":"Tanay","year":"2021","journal-title":"J Cancer Surviv"},{"key":"10.1016\/j.jtos.2021.06.007_bib59","article-title":"The effects of exercise on chemotherapy-induced peripheral neuropathy symptoms in cancer patients: a systematic review and meta-analysis","author":"Lin","year":"2021","journal-title":"Support Care Canc"},{"key":"10.1016\/j.jtos.2021.06.007_bib60","doi-asserted-by":"crossref","first-page":"255","DOI":"10.4103\/apjon.apjon-2075","article-title":"Cold application and exercise on development of peripheral neuropathy during taxane chemotherapy in breast cancer patients: a randomized controlled trial","volume":"8","author":"\u015eim\u015fek","year":"2021","journal-title":"Asia Pac J Oncol Nurs"},{"key":"10.1016\/j.jtos.2021.06.007_bib61","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/17425255.2017.1258400","article-title":"Chemotherapy-induced peripheral neurotoxicity-outcome measures: the issue","volume":"13","author":"Alberti","year":"2017","journal-title":"Expet Opin Drug Metabol Toxicol"},{"key":"10.1016\/j.jtos.2021.06.007_bib62","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1097\/WCO.0000000000000724","article-title":"Toxic neuropathies: chemotherapy-induced peripheral neurotoxicity","volume":"32","author":"Alberti","year":"2019","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.jtos.2021.06.007_bib63","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jpain.2019.06.011","article-title":"Quantification of small fiber neuropathy in chemotherapy treated patients","volume":"21","author":"Timmins","year":"2020","journal-title":"J Pain"},{"key":"10.1016\/j.jtos.2021.06.007_bib64","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1212\/01.WNL.0000092015.03923.19","article-title":"Grading of chemotherapy-induced peripheral neurotoxicity using the Total Neuropathy Scale","volume":"61","author":"Cavaletti","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.jtos.2021.06.007_bib65","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1212\/WNL.53.8.1660","article-title":"Total neuropathy score: validation and reliability study","volume":"53","author":"Cornblath","year":"1999","journal-title":"Neurology"},{"issue":"Suppl 2","key":"10.1016\/j.jtos.2021.06.007_bib66","first-page":"S13","article-title":"Overview and critical revision of clinical assessment tools in chemotherapy-induced peripheral neurotoxicity","volume":"24","author":"Park","year":"2019","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.jtos.2021.06.007_bib67","first-page":"4459","article-title":"Taxane-induced peripheral neuropathy: differences in patient report and objective assessment","volume":"28","author":"Timmins","year":"2020","journal-title":"Support Care Canc"},{"key":"10.1016\/j.jtos.2021.06.007_bib68","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s42466-020-00064-2","article-title":"Diagnosis of peripheral neuropathy","volume":"2","author":"Lehmann","year":"2020","journal-title":"Neurol Res Pract"},{"key":"10.1016\/j.jtos.2021.06.007_bib69","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S1053-4296(03)00031-6","article-title":"CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment","volume":"13","author":"Trotti","year":"2003","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.jtos.2021.06.007_bib70","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.ejca.2005.02.012","article-title":"The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: the QLQ-CIPN20","volume":"41","author":"Postma","year":"2005","journal-title":"Eur J Canc"},{"key":"10.1016\/j.jtos.2021.06.007_bib71","first-page":"741","article-title":"Psychometric evaluation of the functional assessment of cancer therapy\/gynecologic oncology group\u2014neurotoxicity (Fact\/GOG-Ntx) questionnaire for patients receiving systemic chemotherapy","volume":"13","author":"Calhoun","year":"2003","journal-title":"Int J Gynecol Canc"},{"key":"10.1016\/j.jtos.2021.06.007_bib72","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1007\/s12035-018-1301-8","article-title":"Targeting axon integrity to prevent chemotherapy-induced peripheral neuropathy","volume":"56","author":"Chine","year":"2019","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.jtos.2021.06.007_bib73","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jpainsymman.2006.08.006","article-title":"Dysfunction in multiple primary afferent fiber subtypes revealed by quantitative sensory testing in patients with chronic vincristine-induced pain","volume":"33","author":"Dougherty","year":"2007","journal-title":"J Pain Symptom Manag"},{"key":"10.1016\/j.jtos.2021.06.007_bib74","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1080\/17425255.2021.1842873","article-title":"A review of novel biomarkers and imaging techniques for assessing the severity of chemotherapy-induced peripheral neuropathy","volume":"16","author":"Alberti","year":"2020","journal-title":"Expet Opin Drug Metabol Toxicol"},{"key":"10.1016\/j.jtos.2021.06.007_bib75","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/ene.14035","article-title":"Early changes in tests of peripheral nerve function during oxaliplatin treatment and their correlation with chemotherapy-induced polyneuropathy symptoms and signs","volume":"27","author":"Kr\u00f8ig\u00e5rd","year":"2020","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jtos.2021.06.007_bib76","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1080\/02713683.2019.1705984","article-title":"A comparative study on the diagnostic utility of corneal confocal microscopy and tear neuromediator levels in diabetic peripheral neuropathy","volume":"45","author":"Tummanapalli","year":"2020","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.jtos.2021.06.007_bib77","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/01.ico.0000154384.05614.8f","article-title":"Epithelial innervation of human cornea: a three-dimensional study using confocal laser scanning fluorescence microscopy","volume":"24","author":"Guthoff","year":"2005","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2021.06.007_bib78","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/aos.13844","article-title":"Role of corneal nerves in ocular surface homeostasis and disease","volume":"97","author":"Labetoulle","year":"2019","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.jtos.2021.06.007_bib79","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1038\/s41598-020-60422-7","article-title":"Corneal confocal microscopy detects small nerve fibre damage in patients with painful diabetic neuropathy","volume":"10","author":"Kalteniece","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtos.2021.06.007_bib80","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1111\/dme.14306","article-title":"Associations between acute glucose control and peripheral nerve structure and function in type 1 diabetes","volume":"37","author":"Issar","year":"2020","journal-title":"Diabet Med"},{"key":"10.1016\/j.jtos.2021.06.007_bib81","doi-asserted-by":"crossref","first-page":"671","DOI":"10.2337\/dc14-2114","article-title":"Corneal confocal microscopy predicts 4-year incident peripheral neuropathy in type 1 diabetes","volume":"38","author":"Pritchard","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jtos.2021.06.007_bib82","doi-asserted-by":"crossref","first-page":"P71","DOI":"10.1016\/j.ophtha.2020.10.022","article-title":"Primary open-angle glaucoma preferred practice Pattern\u00ae","volume":"128","author":"Gedde","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2021.06.007_bib83","doi-asserted-by":"crossref","first-page":"660203","DOI":"10.3389\/fimmu.2021.660203","article-title":"Cutaneous neuroimmune interactions in peripheral neuropathic pain states","volume":"12","author":"Lowy","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtos.2021.06.007_bib84","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0170814","article-title":"Characterisation of immune and neuroinflammatory changes associated with chemotherapy-induced peripheral neuropathy","volume":"12","author":"Makker","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.jtos.2021.06.007_bib85","doi-asserted-by":"crossref","first-page":"135941","DOI":"10.1016\/j.neulet.2021.135941","article-title":"Role of innate immunity in chemotherapy-induced peripheral neuropathy","volume":"755","author":"Uhelski","year":"2021","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jtos.2021.06.007_bib86","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.jtos.2019.07.001","article-title":"Corneal epithelial dendritic cell density in the healthy human cornea: a meta-analysis of in-vivo confocal microscopy data","volume":"17","author":"Mobeen","year":"2019","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2021.06.007_bib87","doi-asserted-by":"crossref","first-page":"14248","DOI":"10.1038\/s41598-018-32410-5","article-title":"Dendritic cell maturation in the corneal epithelium with onset of type 2 diabetes is associated with tumor necrosis factor receptor superfamily member 9","volume":"8","author":"Lagali","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtos.2021.06.007_bib88","doi-asserted-by":"crossref","first-page":"108168","DOI":"10.1016\/j.exer.2020.108168","article-title":"In vivo immune cell dynamics in the human cornea","author":"Colorado","year":"2020","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jtos.2021.06.007_bib89","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12974-021-02130-1","article-title":"Corneal confocal microscopy differentiates inflammatory from diabetic neuropathy","volume":"18","author":"Fleischer","year":"2021","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.jtos.2021.06.007_bib90","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jtos.2021.02.007","article-title":"The ocular surface immune system through the eyes of aging","volume":"20","author":"Galletti","year":"2021","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2021.06.007_bib91","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.exer.2013.05.016","article-title":"Corneal innervation as a window to peripheral neuropathies","volume":"113","author":"Ferrari","year":"2013","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jtos.2021.06.007_bib92","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1167\/iovs.10-5688","article-title":"A novel mouse model for neurotrophic keratopathy: trigeminal nerve stereotactic electrolysis through the brain","volume":"52","author":"Ferrari","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2021.06.007_bib93","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/ceo.13685","article-title":"Corneal nerve plexus changes induced by Oxaliplatin chemotherapy and Ergothioneine antioxidant supplementation","volume":"48","author":"Tyler","year":"2020","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.jtos.2021.06.007_bib94","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1038\/s41598-018-20734-1","article-title":"Epothilone B speeds corneal nerve regrowth and functional recovery through microtubule stabilization and increased nerve beading","volume":"8","author":"Wang","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtos.2021.06.007_bib95","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1155\/2016\/5056418","article-title":"Effects of microtubule stabilization by epothilone B depend on the type and age of neurons","volume":"2016","author":"Jang","year":"2016","journal-title":"Neural Plast"},{"key":"10.1016\/j.jtos.2021.06.007_bib96","doi-asserted-by":"crossref","first-page":"4972","DOI":"10.1167\/iovs.19-28519","article-title":"Comparative anatomy of the mammalian corneal subbasal nerve plexus","volume":"60","author":"Marfurt","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2021.06.007_bib97","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1038\/s41385-018-0031-6","article-title":"The mouse autonomic nervous system modulates inflammation and epithelial renewal after corneal abrasion through the activation of distinct local macrophages","volume":"11","author":"Xue","year":"2018","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.jtos.2021.06.007_bib98","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/SPC.0000000000000204","article-title":"Chemotherapy-induced painful neuropathy: pain-like behaviours in rodent models and their response to commonly used analgesics","volume":"10","author":"Hopkins","year":"2016","journal-title":"Curr Opin Support Palliat Care"},{"key":"10.1016\/j.jtos.2021.06.007_bib99","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0221787","article-title":"A systematic summary and comparison of animal models for chemotherapy induced (peripheral) neuropathy (CIPN)","volume":"14","author":"Gadgil","year":"2019","journal-title":"PloS One"},{"key":"10.1016\/j.jtos.2021.06.007_bib100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000243","article-title":"Animal models of chemotherapy-induced peripheral neuropathy: a machine-assisted systematic review and meta-analysis","volume":"17","author":"Currie","year":"2019","journal-title":"PLoS Biol"},{"key":"10.1016\/j.jtos.2021.06.007_bib101","first-page":"110","article-title":"Long-term peripheral neuropathy in breast cancer patients treated with adjuvant chemotherapy: NRG Oncology\/NSABP B-30","author":"Bandos","year":"2018","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jtos.2021.06.007_bib102","doi-asserted-by":"crossref","first-page":"113154","DOI":"10.1016\/j.expneurol.2019.113154","article-title":"Methods for in vivo studies in rodents of chemotherapy induced peripheral neuropathy","volume":"325","author":"Bruna","year":"2020","journal-title":"Exp Neurol"},{"key":"10.1016\/j.jtos.2021.06.007_bib103","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/00003226-200105000-00008","article-title":"Morphology of corneal nerves using confocal microscopy","volume":"20","author":"Oliveira-Soto","year":"2001","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2021.06.007_bib104","series-title":"ConfoScan4 operator's manual","author":"Nidek Technologies","year":"2005"},{"key":"10.1016\/j.jtos.2021.06.007_bib105","series-title":"Heidelberg Retina Tomograph, Rostock Cornea Module for HRT II with smart converter box and HRT3 user manual software version 1.3","author":"GmbH","year":"2013"},{"key":"10.1016\/j.jtos.2021.06.007_bib106","first-page":"435","article-title":"Clinical applications of corneal confocal microscopy","volume":"2","author":"Tavakoli","year":"2008","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jtos.2021.06.007_bib107","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.media.2011.05.016","article-title":"Automatic analysis of diabetic peripheral neuropathy using multi-scale quantitative morphology of nerve fibres in corneal confocal microscopy imaging","volume":"15","author":"Dabbah","year":"2011","journal-title":"Med Image Anal"},{"key":"10.1016\/j.jtos.2021.06.007_bib108","first-page":"300","article-title":"Dual-model automatic detection of nerve-fibres in corneal confocal microscopy images","volume":"13","author":"Dabbah","year":"2010","journal-title":"Med image Comput Comput Assist Interv"},{"key":"10.1016\/j.jtos.2021.06.007_bib109","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1109\/TBME.2016.2573642","article-title":"An automatic tool for quantification of nerve fibers in corneal confocal microscopy images","volume":"64","author":"Chen","year":"2017","journal-title":"IEEE Trans Biomed Eng"},{"key":"10.1016\/j.jtos.2021.06.007_bib110","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1097\/ICO.0000000000000152","article-title":"Fully automated, semiautomated, and manual morphometric analysis of corneal subbasal nerve plexus in individuals with and without diabetes","volume":"33","author":"Dehghani","year":"2014","journal-title":"Cornea"},{"issue":"5","key":"10.1016\/j.jtos.2021.06.007_bib111","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/ICO.0000000000002549","article-title":"Validation of a novel confocal microscopy imaging protocol with assessment of reproducibility and comparison of nerve metrics in dry eye disease compared with controls","volume":"40","author":"Takhar","year":"2021","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2021.06.007_bib112","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.2337\/dc14-2422","article-title":"Small nerve fiber quantification in the diagnosis of diabetic sensorimotor polyneuropathy: comparing corneal confocal microscopy with intraepidermal nerve fiber density","volume":"38","author":"Chen","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jtos.2021.06.007_bib113","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.jdiacomp.2016.07.024","article-title":"Agreement between automated and manual quantification of corneal nerve fiber length: implications for diabetic neuropathy research","volume":"31","author":"Scarr","year":"2017","journal-title":"J Diabet Complicat"},{"key":"10.1016\/j.jtos.2021.06.007_bib114","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.diabres.2019.03.039","article-title":"Quantitative analysis of corneal nerve fibers in type 2 diabetics with and without diabetic peripheral neuropathy: comparison of manual and automated assessments","volume":"151","author":"Li","year":"2019","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jtos.2021.06.007_bib115","doi-asserted-by":"crossref","first-page":"838","DOI":"10.2337\/dc14-2311","article-title":"Normative values for corneal nerve morphology assessed using corneal confocal microscopy: a multinational normative data set","volume":"38","author":"Tavakoli","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jtos.2021.06.007_bib116","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1167\/tvst.9.9.43","article-title":"The utility of corneal nerve fractal dimension analysis in peripheral neuropathies of different etiology","volume":"9","author":"Petropoulos","year":"2020","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.jtos.2021.06.007_bib117","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jocn.2017.02.033","article-title":"Corneal nerve microstructure in Parkinson's disease","volume":"39","author":"Misra","year":"2017","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.jtos.2021.06.007_bib118","article-title":"Corneal confocal microscopy identifies greater corneal nerve damage in patients with a recurrent compared to first ischemic stroke","volume":"15","author":"Khan","year":"2020","journal-title":"PloS One"},{"key":"10.1016\/j.jtos.2021.06.007_bib119","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/jns.12360","article-title":"Reduced association between dendritic cells and corneal sub-basal nerve fibers in patients with fibromyalgia syndrome","volume":"25","author":"Klitsch","year":"2020","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.jtos.2021.06.007_bib120","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1177\/1352458516677590","article-title":"Patients with multiple sclerosis demonstrate reduced subbasal corneal nerve fibre density","volume":"23","author":"Mikolajczak","year":"2017","journal-title":"Mult Scler"},{"key":"10.1016\/j.jtos.2021.06.007_bib121","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s11892-019-1212-8","article-title":"Epidemiology of peripheral neuropathy and lower extremity disease in diabetes","volume":"19","author":"Hicks","year":"2019","journal-title":"Curr Diabetes Rep"},{"key":"10.1016\/j.jtos.2021.06.007_bib122","doi-asserted-by":"crossref","first-page":"150","DOI":"10.2337\/dc20-1482","article-title":"Diagnosis of neuropathy and risk factors for corneal nerve loss in type 1 and type 2 diabetes: a corneal confocal microscopy study","volume":"44","author":"Ferdousi","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jtos.2021.06.007_bib123","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2020-001801","article-title":"Corneal confocal microscopy compared with quantitative sensory testing and nerve conduction for diagnosing and stratifying the severity of diabetic peripheral neuropathy","volume":"8","author":"Ferdousi","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.jtos.2021.06.007_bib124","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0139394","article-title":"Corneal confocal microscopy detects small fibre neuropathy in patients with upper gastrointestinal cancer and nerve regeneration in chemotherapy induced peripheral neuropathy","volume":"10","author":"Ferdousi","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.jtos.2021.06.007_bib125","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/jns5.12036","article-title":"Corneal confocal microscopy in patients with oxaliplatin-induced peripheral neuropathy","volume":"18","author":"Campagnolo","year":"2013","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.jtos.2021.06.007_bib126","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1212\/WNL.0b013e31822cfc59","article-title":"Longitudinal assessment of oxaliplatin-induced neuropathy","volume":"77","author":"Burakgazi","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.jtos.2021.06.007_bib127","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1097\/OPX.0b013e31824ee8c9","article-title":"Optimal image sample size for corneal nerve morphometry","volume":"89","author":"Vagenas","year":"2012","journal-title":"Optom Vis Sci"},{"key":"10.1016\/j.jtos.2021.06.007_bib128","first-page":"11","article-title":"Burst of corneal dendritic cells during trastuzumab and paclitaxel treatment","author":"Sterenczak","year":"2021","journal-title":"Diagnostics"},{"key":"10.1016\/j.jtos.2021.06.007_bib129","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.jfo.2018.07.005","article-title":"Ocular surface adverse events of systemic epidermal growth factor receptor inhibitors (EGFRi): a prospective trial","volume":"41","author":"Saint-Jean","year":"2018","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.jtos.2021.06.007_bib130","doi-asserted-by":"crossref","DOI":"10.1177\/1758835920907543","article-title":"Corneal side effects induced by EGFR-inhibitor antibody-drug conjugate ABT-414 in patients with recurrent glioblastoma: a prospective clinical and confocal microscopy study","volume":"12","author":"Parrozzani","year":"2020","journal-title":"Ther Adv Med Oncol"},{"key":"10.1016\/j.jtos.2021.06.007_bib131","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1136\/jnnp.2009.177303","article-title":"Non-length-dependent small fibre neuropathy. Confocal microscopy study of the corneal innervation","volume":"81","author":"Gemignani","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jtos.2021.06.007_bib132","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1001\/archneurol.2010.17","article-title":"Chemotherapy-associated peripheral sensory neuropathy assessed using in vivo corneal confocal microscopy","volume":"67","author":"Ferrari","year":"2010","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jtos.2021.06.007_bib133","first-page":"e427","article-title":"Corneal changes in trastuzumab emtansine treatment","volume":"18","author":"Kreps","year":"2018","journal-title":"Clin Breast Canc"},{"key":"10.1016\/j.jtos.2021.06.007_bib134","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/00001813-200409000-00005","article-title":"Peripheral neuropathy associated with capecitabine","volume":"15","author":"Saif","year":"2004","journal-title":"Anti Canc Drugs"},{"key":"10.1016\/j.jtos.2021.06.007_bib135","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s10549-019-05179-y","article-title":"Corneal features in trastuzumab emtansine treatment: not a rare occurrence","volume":"175","author":"Deklerck","year":"2019","journal-title":"Breast Canc Res Treat"},{"key":"10.1016\/j.jtos.2021.06.007_bib136","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20193563","article-title":"Non-invasive detection of corneal sub-basal nerve plexus changes in multiple myeloma patients by confocal laser scanning microscopy","volume":"40","author":"Koschmieder","year":"2020","journal-title":"Biosci Rep"},{"key":"10.1016\/j.jtos.2021.06.007_bib137","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1167\/tvst.10.1.24","article-title":"A cross-sectional study of sub-basal corneal nerve reduction following neurotoxic chemotherapy","volume":"10","author":"Chiang","year":"2021","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.jtos.2021.06.007_bib138","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/dme.13952","article-title":"Relationship between corneal confocal microscopy and markers of peripheral nerve structure and function in Type 2 diabetes","volume":"37","author":"Yan","year":"2020","journal-title":"Diabet Med"},{"key":"10.1016\/j.jtos.2021.06.007_bib139","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1007\/s00125-019-4897-y","article-title":"Early nerve fibre regeneration in individuals with type 1 diabetes after simultaneous pancreas and kidney transplantation","volume":"62","author":"Azmi","year":"2019","journal-title":"Diabetologia"},{"key":"10.1016\/j.jtos.2021.06.007_bib140","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4143\/crt.2016.569","article-title":"S-1\u2013induced lacrimal drainage obstruction and its association with ingredients\/Metabolites of S-1 in tears and plasma: a prospective multi-institutional study","volume":"50","author":"Kim","year":"2018","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.jtos.2021.06.007_bib141","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1365-2125.1979.tb00923.x","article-title":"Serum, tear and salivary concentrations of methotrexate in man","volume":"7","author":"Steele","year":"1979","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jtos.2021.06.007_bib142","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/clpt.1982.93","article-title":"Effects of high-dose cytarabine","volume":"31","author":"Hande","year":"1982","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jtos.2021.06.007_bib143","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1097\/ICO.0b013e31823f0b60","article-title":"Interocular comparison by in vivo confocal microscopy of the 2-dimensional architecture of the normal human corneal subbasal nerve plexus","volume":"31","author":"Misra","year":"2012","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2021.06.007_bib144","doi-asserted-by":"crossref","first-page":"7091","DOI":"10.1167\/iovs.13-12999","article-title":"Standardized baseline human corneal subbasal nerve density for clinical investigations with laser-scanning in vivo confocal microscopy","volume":"54","author":"Parissi","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2021.06.007_bib145","doi-asserted-by":"crossref","first-page":"3646","DOI":"10.2337\/dc13-0193","article-title":"Corneal nerve loss detected with corneal confocal microscopy is symmetrical and related to the severity of diabetic polyneuropathy","volume":"36","author":"Petropoulos","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jtos.2021.06.007_bib146","doi-asserted-by":"crossref","first-page":"186","DOI":"10.3109\/02713683.2015.1010686","article-title":"Local variability of parameters for characterization of the corneal subbasal nerve plexus","volume":"41","author":"Winter","year":"2016","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.jtos.2021.06.007_bib147","doi-asserted-by":"crossref","first-page":"5920","DOI":"10.1364\/BOE.402971","article-title":"Micro-optical coherence tomography for high-resolution morphologic imaging of cellular and nerval corneal micro-structures","volume":"11","author":"Wartak","year":"2020","journal-title":"Biomed Opt Express"},{"key":"10.1016\/j.jtos.2021.06.007_bib148","doi-asserted-by":"crossref","first-page":"5689","DOI":"10.1364\/BOE.397615","article-title":"Multiwavelength confocal laser scanning microscopy of the cornea","volume":"11","author":"Bohn","year":"2020","journal-title":"Biomed Opt Express"},{"key":"10.1016\/j.jtos.2021.06.007_bib149","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1109\/TMI.2020.2974499","article-title":"Automated tortuosity analysis of nerve fibers in corneal confocal microscopy","volume":"39","author":"Zhao","year":"2020","journal-title":"IEEE Trans Med Imag"},{"key":"10.1016\/j.jtos.2021.06.007_bib150","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1097\/ICO.0000000000002294","article-title":"Corneal epithelial \"neuromas\": a case of mistaken identity?","volume":"39","author":"Stepp","year":"2020","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2021.06.007_bib151","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1136\/bjophthalmol-2019-314799","article-title":"Clinical and in vivo confocal microscopic features of neuropathic corneal pain","volume":"104","author":"Ross","year":"2020","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jtos.2021.06.007_bib152","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jtos.2017.05.002","article-title":"TFOS DEWS II pain and sensation report","volume":"15","author":"Belmonte","year":"2017","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2021.06.007_bib153","doi-asserted-by":"crossref","first-page":"5144","DOI":"10.1167\/iovs.13-12370","article-title":"Corneal nerve structure and function in patients with non-sjogren dry eye: clinical correlations","volume":"54","author":"Labbe","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2021.06.007_bib154","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/OPX.0000000000001063","article-title":"Corneal nerve morphology, sensitivity, and tear neuropeptides in contact lens wear","volume":"94","author":"Golebiowski","year":"2017","journal-title":"Optom Vis Sci"},{"key":"10.1016\/j.jtos.2021.06.007_bib155","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jtos.2016.07.005","article-title":"Changes in corneal subbasal nerve morphology and sensitivity during orthokeratology: onset of change","volume":"15","author":"Lum","year":"2017","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2021.06.007_bib156","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.clae.2019.02.011","article-title":"The effect of the duration of diabetes on dry eye and corneal nerves","volume":"42","author":"Lyu","year":"2019","journal-title":"Contact Lens Anterior Eye"},{"key":"10.1016\/j.jtos.2021.06.007_bib157","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1038\/s41598-021-81398-y","article-title":"A cross-sectional study of ocular surface discomfort and corneal nerve dysfunction after paclitaxel treatment for cancer","volume":"11","author":"Chiang","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtos.2021.06.007_bib158","article-title":"Dry eye signs and symptoms in patients on aromatase inhibitor therapy","author":"Khoo","year":"2021","journal-title":"Eye"},{"key":"10.1016\/j.jtos.2021.06.007_bib159","doi-asserted-by":"crossref","first-page":"578233","DOI":"10.3389\/fmed.2021.578233","article-title":"In vivo confocal microscopic evaluation of corneal dendritic cell density and subbasal nerve parameters in dry eye patients: a systematic review and meta-analysis","volume":"8","author":"Xu","year":"2021","journal-title":"Front Med"},{"key":"10.1016\/j.jtos.2021.06.007_bib160","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jtos.2020.03.008","article-title":"The impact of anticancer drugs on the ocular surface","volume":"18","author":"Chiang","year":"2020","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2021.06.007_bib161","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1080\/15569527.2020.1790592","article-title":"A cross-sectional optical coherence tomography study in patients on taxane-based therapy and a case report with the literature review","volume":"39","author":"Kaya","year":"2020","journal-title":"Cutan Ocul Toxicol"},{"key":"10.1016\/j.jtos.2021.06.007_bib162","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s40122-017-0092-3","article-title":"Pain in platin-induced neuropathies: a systematic review and meta-analysis","volume":"7","author":"Brozou","year":"2018","journal-title":"Pain Ther"},{"key":"10.1016\/j.jtos.2021.06.007_bib163","first-page":"1999","article-title":"A systematic review on chronic oxaliplatin-induced peripheral neuropathy and the relation with oxaliplatin administration","volume":"22","author":"Beijers","year":"2014","journal-title":"Support Care Canc"},{"key":"10.1016\/j.jtos.2021.06.007_bib164","first-page":"2959","article-title":"Chemotherapy-induced peripheral neuropathy in newly diagnosed breast cancer survivors treated with taxane: a prospective longitudinal study","volume":"29","author":"Wang","year":"2021","journal-title":"Support Care Canc"},{"key":"10.1016\/j.jtos.2021.06.007_bib165","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s10549-017-4437-8","article-title":"Long-term peripheral neuropathy symptoms in breast cancer survivors","volume":"166","author":"Mustafa Ali","year":"2017","journal-title":"Breast Canc Res Treat"},{"key":"10.1016\/j.jtos.2021.06.007_bib166","first-page":"2661","article-title":"Ixabepilone-associated peripheral neuropathy: data from across the phase II and III clinical trials","volume":"20","author":"Vahdat","year":"2012","journal-title":"Support Care Canc"},{"key":"10.1016\/j.jtos.2021.06.007_bib167","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1177\/1078155219870840","article-title":"Peripheral neuropathy in non-Hodgkin's lymphoma patients receiving vincristine with and without aprepitant\/fosaprepitant","volume":"26","author":"Edwards","year":"2020","journal-title":"J Oncol Pharm Pract"},{"key":"10.1016\/j.jtos.2021.06.007_bib168","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s00280-012-2047-z","article-title":"Persistent chemoneuropathy in patients receiving the plant alkaloids paclitaxel and vincristine","volume":"71","author":"Boyette-Davis","year":"2013","journal-title":"Canc Chemother Pharmacol"},{"key":"10.1016\/j.jtos.2021.06.007_bib169","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1200\/JCO.2010.28.0792","article-title":"Genetic factors underlying the risk of thalidomide-related neuropathy in patients with multiple myeloma","volume":"29","author":"Johnson","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtos.2021.06.007_bib170","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1056\/NEJMoa053583","article-title":"Thalidomide and hematopoietic-cell transplantation for multiple myeloma","volume":"354","author":"Barlogie","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtos.2021.06.007_bib171","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/j.1365-2141.2008.07573.x","article-title":"Reversibility of symptomatic peripheral neuropathy with bortezomib in the phase III APEX trial in relapsed multiple myeloma: impact of a dose-modification guideline","volume":"144","author":"Richardson","year":"2009","journal-title":"Br J Haematol"},{"issue":"Suppl 2","key":"10.1016\/j.jtos.2021.06.007_bib172","first-page":"S52","article-title":"Bortezomib and other proteosome inhibitors-induced peripheral neurotoxicity: from pathogenesis to treatment","volume":"24","author":"Velasco","year":"2019","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.jtos.2021.06.007_bib173","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1200\/JCO.2006.07.8659","article-title":"Bortezomib is active in patients with untreated or relapsed Waldenstr\u00f6m's macroglobulinemia: a phase II study of the National Cancer Institute of Canada Clinical Trials Group","volume":"25","author":"Chen","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtos.2021.06.007_bib174","doi-asserted-by":"crossref","first-page":"637593","DOI":"10.3389\/fphar.2021.637593","article-title":"Prevalence of chemotherapy-induced peripheral neuropathy in multiple myeloma patients and its impact on quality of life: a single center cross-sectional study","volume":"12","author":"Selvy","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jtos.2021.06.007_bib175","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJMoa1814017","article-title":"Trastuzumab emtansine for residual invasive HER2-positive breast cancer","volume":"380","author":"von Minckwitz","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtos.2021.06.007_bib176","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1200\/JCO.2016.67.4887","article-title":"Trastuzumab emtansine with or without pertuzumab versus trastuzumab plus taxane for human epidermal growth factor receptor 2-positive, advanced breast cancer: primary results from the phase III MARIANNE study","volume":"35","author":"Perez","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtos.2021.06.007_bib177","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1080\/10428194.2019.1605068","article-title":"Clinical and neurophysiological serial assessments of brentuximab vedotin-associated peripheral neuropathy","volume":"60","author":"Mariotto","year":"2019","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jtos.2021.06.007_bib178","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1182\/blood-2017-05-780049","article-title":"Five-year results of brentuximab vedotin in patients with relapsed or refractory systemic anaplastic large cell lymphoma","volume":"130","author":"Pro","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jtos.2021.06.007_bib179","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s00417-018-04225-7","article-title":"In vivo confocal microscopy morphometric analysis of corneal subbasal nerve plexus in dry eye disease using newly developed fully automated system","volume":"257","author":"Giannaccare","year":"2019","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jtos.2021.06.007_bib180","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1167\/iovs.61.3.48","article-title":"Diabetic neuropathy is characterized by progressive corneal nerve fiber loss in the central and inferior whorl regions","volume":"61","author":"Ferdousi","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2021.06.007_bib181","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1167\/iovs.17-23342","article-title":"Corneal nerve fractal dimension: a novel corneal nerve metric for the diagnosis of diabetic densorimotor polyneuropathy","volume":"59","author":"Chen","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2021.06.007_bib182","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1136\/bjophthalmol-2019-315449","article-title":"Bilateral morphometric analysis of corneal sub-basal nerve plexus in patients undergoing unilateral cataract surgery: a preliminary in vivo confocal microscopy study","volume":"105","author":"Giannaccare","year":"2020","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jtos.2021.06.007_bib183","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.2337\/db07-0285","article-title":"Surrogate markers of small fiber damage in human diabetic neuropathy","volume":"56","author":"Quattrini","year":"2007","journal-title":"Diabetes"}],"container-title":["The Ocular Surface"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012421000574?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012421000574?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:45:50Z","timestamp":1761540350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542012421000574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":183,"alternative-id":["S1542012421000574"],"URL":"https:\/\/doi.org\/10.1016\/j.jtos.2021.06.007","relation":{},"ISSN":["1542-0124"],"issn-type":[{"value":"1542-0124","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Corneal nerve changes following treatment with neurotoxic anticancer drugs","name":"articletitle","label":"Article Title"},{"value":"The Ocular Surface","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtos.2021.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}